Acute Agitation and Aggression Treatment Market Report 2024 (Global Edition)

Global Acute Agitation and Aggression Treatment Market Report 2024 Market Size Split by Treatment Approach (Behavioral Approaches, Environmental Interventions, Pharmacologic Approaches (Drugs)), by Ro...

Acute Agitation and Aggression Treatment Market Report Description

We have various report editions of Acute Agitation and Aggression Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Acute Agitation and Aggression Treatment Market

The major players adopt fresh approaches quickly to gain a competitive advantage and take an important part of the market. To serve a sizable customer base and obtain a competitive advantage, the key players in the Acute Agitation and Aggression Treatment market place a strong emphasis on growing their inventive products.

Acute Agitation and Aggression Treatment Industry News

• June 2022, Positive outcomes from the phase III clinical study of brexpiprazole for the treatment of agitation in individuals with Alzheimer's dementia were announced by H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd.

(Source: www.otsuka.co.jp/en/company/newsreleases/2022/20220627_1.html)

Top Companies Market Share in Acute Agitation and Aggression Treatment Industry: (In no particular order of Rank)

• Eli Lilly and Company
• Pfizer
• Ono Pharmaceutical
• Otsuka Holdings
• GlaxoSmithKline
• Bristol-Myers Squibb
• Johnson & Johnson
• H. Lundbeck A/S
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North American Acute Agitation and Aggression Treatment Market share was 40% of the total market

According to Cognitive Market Research, North America led the market in 2023 and generated around 40% of worldwide revenue. The region's concentration on novel treatment methods and sophisticated healthcare infrastructure facilitates the expansion. The need for comprehensive therapies is increasing due to the rising frequency of mental health issues, with North America being identified as a major growth hub for this industry.

Europe is the fastest-growing category as The market expansion is facilitated by the region's strong healthcare infrastructure and emphasis on patient-centered treatment. The increasing occurrence of mental health illnesses is driving up need for sophisticated interventions, and this is establishing Europe as a major driver of market expansion.

The current report Scope analyzes Acute Agitation and Aggression Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Acute Agitation and Aggression Treatment Market

According to Cognitive Market Research, the global Acute Agitation And Aggression Treatment market size was estimated at USD 5142.5 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2057.00 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2023 to 2030. The market for acute agitation and aggression treatment is expanding significantly in North America due to improved healthcare infrastructure and a greater emphasis on mental health. The market serves a wide spectrum of patients in different healthcare environments, such as mental health centers and hospitals. The need for specialist therapies is growing as more people become aware of the connection between agitation and violence and mental health issues. North America's commitment to innovative healthcare solutions places it as a major location for market expansion, meeting the pressing demand for effective interventions in controlling acute episodes of behavioral difficulties. The area has played a significant role in shaping the market for acute agitation and aggression treatment, as evidenced by its proactive approach to mental health care.

• According to Cognitive Market Research, the US had a major share in the Acute Agitation And Aggression Treatments market with a market size of USD 1622.97 million in 2023 and is projected to grow at a CAGR of 3.2% during the forecast period. This is majorly due to the growing demand for mental health. 
• The Canada Acute Agitation And Aggression Treatments market had a market share of USD 246.84 million in 2023 and is projected to grow at a CAGR of 4.2% during the forecast period. This is due to the increased economy. 
• The Mexico Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 3.9% during the forecast period with a market size of USD 187.19 million in 2023.

Europe Acute Agitation and Aggression Treatment Market

According to Cognitive Market Research, with a market value of USD 5142.5 million in 2023 and projected to expand at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030, Europe accounted for a share of over 30% of the global market size of USD 1542.75 million. A progressive approach to mental health care and more understanding of behavioral issues are driving significant growth in the acute agitation and aggression treatment market in Europe. This market provides services to a wide range of patients in hospitals and psychiatric care institutions, among other healthcare settings. The market is growing as a result of the increased frequency of mental health issues and the strong healthcare system. With a focus on providing efficient solutions, Europe's concentration on patient-centered care places the continent as a major role in handling acute agitation and aggressiveness. The European market for acute aggression and agitation treatment is changing, which is indicative of the region's dedication to improving mental health services and offering all-inclusive solutions to people with behavioral issues.

• According to Cognitive Market Research, the Germany Acute Agitation And Aggression Treatments market size was valued at USD 305.46 million in 2023 and is projected to grow at a CAGR of 3.9% during the forecast period. This is majorly due to the increased awareness of mental health concerns. 
• The United Kingdom Acute Agitation And Aggression Treatments market had a market share of USD 259.18 million in 2023 and is projected to grow at a CAGR of 4.5% during the forecast period. This is due to the emphasis on all-encompassing healthcare solutions. 
• The France Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 2.9% during the forecast period with a market size of USD 141.93 million in 2023.
• The Italy Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 132.68 million in 2023.
• The Russia Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 2.7% during the forecast period with a market size of USD 239.13 million in 2023.
• The Spain Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 2.8% during the forecast period with a market size of USD 126.51 million in 2023.
• The Portugal Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 3.5% during the forecast period with a market size of USD 32.40 million in 2023.
• The Luxembourg Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 3.8% during the forecast period with a market size of USD 47.83 million in 2023.
• The Greece Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 4.0% during the forecast period with a market size of USD 18.51 million in 2023.
• The Rest of Europe Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 2.4% during the forecast period with a market size of USD 239.13 million in 2023.

Asia Pacific Acute Agitation and Aggression Treatment Market

According to Cognitive Market Research, the global Acute Agitation And Aggression Treatment market size was estimated at USD 5142.5 Million out of which Asia Pacific held the market of more than 23% of the global revenue with a market size of USD 1182.78 million in 2023 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030. The market for acute agitation and aggressiveness treatment is expanding significantly in Asia Pacific as a result of growing awareness of the problems associated with agitation and aggression as well as a greater emphasis on mental health. The market serves a range of patient demands in hospitals and psychiatric care institutions, among other healthcare settings. The market is developing as a result of the increasing frequency of mental health issues in the area. Due to its innovative solutions and dynamic healthcare ecosystem, Asia Pacific is well-positioned to address acute episodes of behavioral difficulties. The market for acute agitation and aggression treatment in Asia Pacific shows the region's changing approach to mental health care and its attempts to address the demand for efficient therapies, as awareness and healthcare infrastructure continue to develop.

• According to Cognitive Market Research, the China Acute Agitation And Aggression Treatments market size was valued at USD 532.25 million in 2023 and is projected to grow at a CAGR of 6.7% during the forecast period. This is majorly due to the growing demand for a proactive approach to tackling behavioral issues. 
• The India Acute Agitation And Aggression Treatments market had a market share of USD 141.93 million in 2023 and is projected to grow at a CAGR of 9.0% during the forecast period. This is due to the quick industrialization. 
• The Japan Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 163.22 million in 2023.
• The South Korea Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 6.3% during the forecast period with a market size of USD 118.28 million in 2023.
• The Australia Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 6.9% during the forecast period with a market size of USD 61.50 million in 2023.
• The South East Asia Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 8.2% during the forecast period with a market size of USD 81.61 million in 2023.
• The Rest of Asia Pacific Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 7.0% during the forecast period with a market size of USD 83.98 million in 2023.

South America Acute Agitation and Aggression Treatment Market

According to Cognitive Market Research, the global Acute Agitation And Aggression Treatments market size was estimated at USD 5142.5 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 257.13 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.6% from 2023 to 2030. The market for acute agitation and aggression treatment is expanding in Latin America as a result of rising awareness of mental health issues and the need for all-encompassing care. The market serves a wide range of patient demographics in different healthcare environments, such as psychiatric hospitals and clinics. The region of Latin America is positioned to play a big role in tackling acute agitation and aggression due to its expanding healthcare landscape and growing awareness. The market adapts to the particular requirements of people with behavioral health issues, supporting larger initiatives to enhance mental health services throughout Latin America. The market for acute aggression and agitation treatment in Latin America is critical to improving the standard of care for patients undergoing acute behavioral episodes as awareness of the issue grows.

• According to Cognitive Market Research, the Brazil Acute Agitation And Aggression Treatments market size was valued at USD 110.05 million in 2023 and is projected to grow at a CAGR of 5.2% during the forecast period. This is majorly due to rising demand for successful interventions. 
• The Argentina Acute Agitation And Aggression Treatments market had a market share of USD 43.20 million in 2023 and is projected to grow at a CAGR of 5.5% during the forecast period. This is due to the increased awareness. 
• The Colombia Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD 22.88 million in 2023.
• The Peru Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD 21.08 million in 2023.
• The Chile Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 4.9% during the forecast period with a market size of USD 18.51 million in 2023.
• The Rest of Latin America Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD 41.40 million in 2023.

Middle East and Africa Acute Agitation and Aggression Treatment Market

According to Cognitive Market Research, the global Acute Agitation And Aggression Treatment market size was estimated at USD 5142.5 Million out of which Middle East and Africa held the major market of more than 2% of the global revenue with a market size of USD 102.85 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. The market for acute agitation and aggression treatment is expanding throughout the Middle East and Africa, driven by rising mental health awareness and a greater emphasis on offering specialist care. The market serves a range of patient demands in hospitals and psychiatric care institutions, among other healthcare settings. Because of its distinct healthcare system and growing knowledge of mental health issues, the area is well-positioned to handle acute agitation and aggressiveness. The market contributes to the larger initiatives to improve mental health care in the Middle East and Africa by improving the general quality of care for those with behavioral issues.

• According to Cognitive Market Research, the GCC Countries Acute Agitation And Aggression Treatments market size was valued at USD 44.02 million in 2023 and is projected to grow at a CAGR of 5.7% during the forecast period. This is majorly due to the country's sophisticated healthcare system. 
• The South Africa Acute Agitation And Aggression Treatments market had a market share of USD 16.25 million in 2023 and is projected to grow at a CAGR of 5.9% during the forecast period. This is due to the increased emphasis on mental health. 
• The Egypt Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD 10.80 million in 2023.
• The Turkey Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 4.4% during the forecast period with a market size of USD 8.85 million in 2023.
• The Nigeria Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 4.0% during the forecast period with a market size of USD 10.80 million in 2023.
• The Rest of MEA Acute Agitation And Aggression Treatments market is projected to witness growth at a CAGR of 3.9% during the forecast period with a market size of USD 12.14 million in 2023.

Acute Agitation and Aggression Treatment Market Analysis

Acute Agitation and Aggression Treatment Treatment Approach Segment Analysis

According to Cognitive Market Research, Behavioural Approaches held the major market share over the forecast period. To lessen inputs and triggers that contribute to agitation and hostility, these interventions entail making physical environment modifications. The market is witnessing a growing emphasis on customized environmental strategies as healthcare practitioners realize the influence of surroundings on patient behavior. This is leading to more efficient and patient-centered treatment approaches.

Environmental Interventions are the fastest-growing category over the forecast period. With acute behavioral issues linked to this common mental health disease, there is a growing market need for focused pharmaceutical and non-pharmacological therapies. Taking into account the particular requirements of people with schizophrenia helps the market expand and leads to the creation of specialized treatment methods.

• Behavioral Approaches
• Environmental Interventions
• Pharmacologic Approaches (Drugs)

 

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Acute Agitation and Aggression Treatment Industry. Request a Free Sample PDF!

Acute Agitation and Aggression Treatment Application Segment Analysis

According to Cognitive Market Research, Oral is prominent in the market. The advent of oral medicines has made addressing acute agitation and aggression more convenient and efficient. The market is witnessing a growing emphasis on oral formulations as healthcare professionals prioritize patient-friendly treatment modalities, leading to an overall expansion of treatment alternatives.

Intramuscular are the fastest-growing category over the forecast period as Effective interventions are becoming more and more necessary in these healthcare settings to address acute behavioral issues. The need for specialist therapies increases with increased awareness and diagnosis, which fuels the expansion of the market for facilities that serve patients with acute agitation and aggression in a range of medical settings.

• Oral
• Intramuscular
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Acute Agitation and Aggression Treatment Indication Segment Analysis

According to Cognitive Market Research, Schizophrenia holds a prominent market share. Effective therapies are in greater demand as behavioral difficulties associated with dementia become increasingly common. In response, the market expands by concentrating on creating and offering specialist interventions to deal with acute agitation and violence in dementia patients.

Dementia is the fastest-growing category over the forecast period. The advent of oral medicines has made addressing acute agitation and aggression more convenient and efficient. The market is witnessing a growing emphasis on oral formulations as healthcare professionals prioritize patient-friendly treatment modalities, which is leading to an overall expansion of treatment alternatives.

• Schizophrenia
• Dementia
• Bipolar Disorder
• Depression
• Drug-induced Agitation and Aggression
• Alcohol Withdrawal
• Others

Acute Agitation and Aggression Treatment End-User Segment Analysis

According to Cognitive Market Research, hospitals & ambulatory surgical centers, hold a prominent market share Effective interventions are becoming more and more necessary in these healthcare settings to address acute behavioral issues. The need for specialist therapies increases with increased awareness and diagnosis, which fuels the expansion of the market for facilities that serve patients with acute agitation and aggression in a range of medical settings.

The psychiatric care facilities is the fastest-growing category over the forecast period These facilities, which provide specialized mental health care, frequently deal with acute behavioral problems. The market is expanding due largely to the necessity for comprehensive treatment plans and focused interventions in mental care facilities. These programs are designed to meet the specific needs of patients who are suffering acute agitation and violence.

• Hospitals & Ambulatory Surgical Centers
• Psychiatric Care Facilities
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion